Börseninformationen
| DAX | TecDAX | Dow Jones |
|---|---|---|
|
|
||
| Aktuell: 49.141,93 Diff.%: -0,05% Kurszeit: 28.04. 22:42 | ||
Top/Flop
| DAX | Kurs | Zeit | Diff.% | |
|---|---|---|---|---|
 |
MERCK KGAA O.N. | 111,450 | 17:36 | +2,11% |
|
COMMERZBANK AG | 35,480 | 17:39 | +2,10% |
|
QIAGEN NV EO -,01 | 29,125 | 17:39 | -10,76% |
|
BAYER AG NA O.N. | 36,620 | 17:36 | -4,59% |
| TecDAX | Kurs | Zeit | Diff.% | |
|
SMA SOLAR TECHNOL.AG | 51,900 | 17:35 | +3,28% |
|
CANCOM SE O.N. | 24,800 | 17:35 | +1,22% |
|
QIAGEN NV EO -,01 | 29,125 | 17:39 | -10,76% |
|
EVOTEC SE INH O.N. | 5,140 | 17:35 | -3,11% |
| Dow Jones | Kurs | Zeit | Diff.% | |
|
Coca-Cola Company | 78,350 | 02:04 | +3,86% |
|
Unitedhealth Group | 366,770 | 02:04 | +3,41% |
|
Sherwin-Williams Company (The) | 324,270 | 02:04 | -3,52% |
|
NVIDIA Corp | 213,170 | 23:31 | -1,63% |
- Marktüberblick
-
| Name | Kurs | Zeit | Diff.% | ||
|---|---|---|---|---|---|
|
 |
DAX | 24.018,26 | 17:50 | -0,27% |
|
|
HDAX | 12.723,68 | 17:50 | -0,34% |
|
|
MDAX | 30.057,46 | 17:50 | -1,00% |
|
|
TECDAX | 3.596,65 | 17:50 | -1,51% |
|
|
Euro Stoxx 50 | 5.836,10 | 17:50 | -0,41% |
|
|
DOW JONES IND. | 49.141,93 | 22:42 | -0,05% |
|
|
NASDAQ COMPOSITE IND | 24.663,80 | 23:16 | -0,90% |
|
S&P 500 | 7.138,80 | 22:20 | -0,49% | |
|
NIKKEI 225 INDEX | 59.793,59 | 08:30 | -1,23% | |
|
UMLAUFR. ALLER OEFFE | 3,03% | 13:45 | +0,66% | |
|
EURO-BUND-FUTURE | 125,01 | 03:54 | -0,10% | |
|
EUR/USD SPOT | 1,1716 | 04:10 | +0,02% |
Marktberichte
| Zeit | Schlagzeilen |
|---|---|
| 28.04. / 23:40 | BUSINESS WIRE: Vensica Medical erhält von der F |
| 28.04. / 22:44 | BUSINESS WIRE: Europäische ServiceNow-Strategi |
| 28.04. / 22:36 | ROUNDUP/Aktien New York Schluss: KI-Aktien schw |
| 28.04. / 22:34 | EQS-Adhoc: Alexanderwerk AG: Bilanzierungsfehler i |
| 28.04. / 22:16 | Aktien New York Schluss: KI-Aktien belasten Nasdaq |
| 28.04. / 19:54 | Aktien New York: KI-Aktien belasten Nasdaq-Börse - |
| 28.04. / 19:53 | EQS-Adhoc: Scout24 SE beschließt, zweite Tranche |
| 28.04. / 19:37 | BUSINESS WIRE: Taiho Oncology, Taiho Pharmaceu |
| ...mehr | |
